Edaravone suspension for oral administration | Patent Publication Number 20200268712

US 20200268712 A1
Patent NumberUS 10987341 B2
Application Number16872741
Filled DateMay 12, 2020
Priority DateNov 1, 2019
Publication DateAug 27, 2020
Original AssigneeMitsubishi Chemical Group Corporation
Current AssigneeMitsubishi Chemical Group Corporation
Inventor/ApplicantsTadashi Miyazawa
Tetsuo Hayama
Kouji Hayashi
Tomohiro Takahashi
Munetomo Matsuda
Tomoyuki Omura
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.